MEF2A
MEF2A (myocyte enhancer factor 2A, also known as RSRFC4 and RSRFC9) is a nuclear DNA-binding transcription factor of the MEF2 family. It activates muscle-specific, growth factor-induced and stress-induced genes, and contributes to muscle development and neuronal differentiation. Browse Assay Genie's current range of MEF2A research reagents below, or read on for the biology behind the target.
MEF2A is a transcriptional activator that binds specifically to the MEF2 element, 5'-YTA[AT](4)TAR-3', found in numerous muscle-specific genes. It is also involved in activating many growth factor- and stress-induced genes. The protein can act as a homodimer or as a heterodimer, and it mediates cellular functions in skeletal and cardiac muscle development as well as in neuronal differentiation and survival.
MEF2A plays diverse roles in the control of cell growth, survival and apoptosis through p38 MAPK signalling, in muscle-specific and/or growth factor-related transcription. In cerebellar granule neurons, phosphorylated and sumoylated MEF2A represses transcription of NUR77, which promotes synaptic differentiation. MEF2A has also been reported to associate with chromatin at the ZNF16 promoter. The protein is located in the nucleus, consistent with its role in gene regulation.
The MEF2A gene belongs to the myocyte enhancer factor 2 group of the MADS box family, alongside related proteins such as MEF2B and MEF2C. It is also known by the earlier symbols RSRFC4 and RSRFC9. Several transcript variants encoding different isoforms have been described. Defects in the gene could be a cause of autosomal dominant coronary artery disease 1 with myocardial infarction (ADCAD1). Mouse and rat each have a Mef2a ortholog.
MEF2A regulates muscle-specific genes through the MEF2 element and contributes to skeletal and cardiac muscle development.
MEF2A mediates neuronal differentiation and survival, including repression of NUR77 transcription in cerebellar granule neurons to promote synaptic differentiation.
MEF2A activates growth factor- and stress-induced genes and acts in p38 MAPK signalling to control cell growth, survival and apoptosis.
Defects in the MEF2A gene could be a cause of autosomal dominant coronary artery disease 1 with myocardial infarction.
MEF2A is a DNA-binding transcription factor that binds the MEF2 element in muscle-specific genes and activates them. It also activates growth factor- and stress-induced genes, and supports skeletal and cardiac muscle development, neuronal differentiation and survival, and the control of cell growth and apoptosis.
MEF2A stands for myocyte enhancer factor 2A, and UniProt lists the protein as myocyte-specific enhancer factor 2A. Earlier aliases are RSRFC4 and RSRFC9. NCBI reports that several transcript variants encode different isoforms, so check the datasheet of any product for its validated reactivity.
MEF2A has orthologs named Mef2a in both mouse and rat. In humans, defects in the gene could be a cause of autosomal dominant coronary artery disease 1 with myocardial infarction (ADCAD1), according to the NCBI Gene summary.
Other MEF2 family transcription factors and related targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q02078; product specifications from Assay Genie datasheets.